Last reviewed · How we verify

NCT03913663

Microsoft Kinect, Gait Function,Hemineglect, Vestibulo-ocular Training

Completed NA Last updated 24 July 2019
What this trial tests

NA trial testing vestibuloocular training in Hemiplegic Gait in 40 participants. Completed in 18 July 2019.

Timeline
22 May 2019
Primary endpoint
15 July 2019
18 July 2019

Quick facts

Lead sponsorBeni-Suef University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date22 May 2019
Primary completion15 July 2019
Estimated completion18 July 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 60 to 70, any sex, with Hemiplegic Gait. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gait problems in hemineglect patient post stroke , vestibuloocular training plays a role in improving gait function, gait assessment using a model based study (Microsoft Kinect) for pre and post training assesment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hemiplegic Gait

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03913663.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing